took $TRAW .51 for swing penny bio with bottom chart and imminent catalyst. - Expected resubmission of the updated toxicology data package to the MHRA by the e

took $TRAW .51 for swing penny bio with bottom chart and imminent catalyst. - Expected resubmission of the updated toxicology data package to the MHRA by the end of Q3 2026. ''The company is preparing an updated toxicology data package for tivoxavir marboxil to support an MHRA resubmission by the e…